Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile Infection (CDI)”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Not applicableStudy completedNCT03848689
What this trial is testing

FQ Restriction for the Prevention of CDI

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionC Difficile Colitis
University of Wisconsin, Madison 5,871
Not applicableEnded earlyNCT01372943
What this trial is testing

Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Queen's University 4
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Testing effectiveness (Phase 2)Study completedNCT01398969
What this trial is testing

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
McMaster University 232
Testing effectiveness (Phase 2)Study completedNCT00772343
What this trial is testing

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Who this might be right for
DiarrheaClostridium Difficile Infection
Sanofi Pasteur, a Sanofi Company 116
Not applicableStudy completedNCT03503474
What this trial is testing

COMBACTE-CDI Understanding the Burden of C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
University of Leeds 3,240
Not applicableNot Yet RecruitingNCT06533800
What this trial is testing

Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection

Who this might be right for
CDI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 24
Testing effectiveness (Phase 2)Study completedNCT04781387
What this trial is testing

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Crestone, Inc 43
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Not applicableUnknownNCT02570477
What this trial is testing

FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment

Who this might be right for
Clostridium Difficile Infection
Chinese University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Large-scale testing (Phase 3)Study completedNCT03244644
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

Who this might be right for
Clostridium Difficile Infection (CDI)
Rebiotix Inc. 320
Not applicableWithdrawnNCT04070352
What this trial is testing

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection (CDI)
University of Pittsburgh
Post-approval studies (Phase 4)Study completedNCT02437591
What this trial is testing

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridium Difficile Infection (CDI)
Astellas Pharma Europe Ltd. 25
Not applicableStudy completedNCT03117582
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Who this might be right for
Clostridium Difficile
University of North Carolina, Chapel Hill 34
Not applicableStudy completedNCT00563186
What this trial is testing

Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

Who this might be right for
Vancomycin Resistant Enterococci InfectionClostridium Difficile InfectionNosocomial Infection+1 more
University of Calgary 1,514
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01085591
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 210
Load More Results